IP Library Granted Patent US 8,975,015
Granted Patent B2
US 8,975,015 · App. 13/102,737 · Granted Mar 10, 2015

Antimicrobial compounds

Inventors: Kevin Rock McClay (Newton, PA); Robert Jon Steffan (Wrightstown, PA)
Assignee: Shaw Intellectual Properties Holding, Inc.
A61K31/423C07D413/04C12Q1/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,975,015
App. No.
13/102,737
Granted
Mar 10, 2015
Kind
B2
Abstract

The compounds disclosed herein are isoxazole derivatives that are useful as antimicrobial compounds, particularly as anti-bacterial compounds. The disclosed methods comprise incubating at least two different substrates in the presence of at least one oxygenase to provide the disclosed compounds, or to prepare and identify compounds that have antimicrobial activity.

Claims (32)

1. A method of preparing and identifying an extract that modulates the growth or replication of a microorganism, the method comprising the steps of:

(a) incubating a first compound and a second compound in the presence of at least one oxygenase to produce the extract;

wherein the first and second compounds are independently selected from the group consisting of indole, indene, isoindoline, 2-azaindole, 3-azaindole, 4-azaindole, 5-azaindole, 6-azaindole, 7-azaindole, benzimidazole, benzamidazoline, imidazopyridine, 4-azabenzamidazole, 5-azabenzamidazole, 6-azabenzamidazole, anthranil, benzisoxazole, and benzoxazole, benzofuran, benzothiophene, benzothiazole, benzoisothiophene, quinoline, isoquinoline, and quinozoline; optionally substituted with at least one —OH, —CH 3 , —NH 2 , —NO 2 , —F, —CI, or —Br substituents;

wherein the at least one oxygenase comprises a toluene monooxygenase;

(b) contacting the microorganism with the extract; and

(c) determining a level of growth or replication of the microorganism;

wherein a difference in the level of growth or replication of the microorganism as compared to the level in a control identifies that the extract modulates the growth or replication of the microorganism.

2. The method of claim 1 , wherein the first and second compounds are independently selected from the group consisting of mono- or poly-substituted indole, indene, isoindoline, 2-azaindole, 3-azaindole, 4-azaindole, 5-azaindole, 6-azaindole, 7-azaindole, benzimidazole, benzamidazoline, imidazopyridine, 4-azabenzamidazole, 5-azabenzamidazole, 6-azabenzamidazole, anthranil, benzisoxazole, benzoxazole, benzofuran, benzothiophene, benzothiazole, benzoisothiophene, quinoline, isoquinoline, and quinozoline; substituted with at least one —OH, —CH 3 , —NH 2 , —NO 2 , —F, —CI, or —Br substituents.

3. The method of claim 1 , wherein the microorganism is a bacterium, virus, fungus, or protozoan.

4. The method of claim 1 , wherein the microorganism is a Gram positive or Gram negative bacterium.

5. The method of claim 1 , wherein the microorganism is M. smegmatis or B. subtilis.

6. The method of claim 1 , wherein the microorganism is M. tuberculosis.

7. The method of claim 1 , wherein the microorganism is multidrug resistant or extensively drug resistant M. tuberculosis.

8. The method of claim 1 , wherein the oxygenase is a toluene-4-monooxygenase.

9. The method of claim 1 , wherein the method further comprises the steps of:

generating one or more test compounds, wherein the first compound is oxidized by the at least one oxygenase to generate at least one first oxidized product, and the second compound is oxidized by the at least one oxygenase to generate at least one second oxidized product; further wherein the at least one first oxidized product and the at least one second oxidized product react to generate one or more test compounds;

wherein the first compound is indole optionally substituted with at least one —OH, —CH 3 , —NH 2 , —NO 2 , —F, —CI, or —Br substituents, and the second compound is selected from the group consisting of indole, indene, isoindoline, 2-azaindole, 3-azaindole, 4-azaindole, 5-azaindole, 6-azaindole, 7-azaindole, benzimidazole, benzamidazoline, imidazopyridine, 4-azabenzamidazole, 5-azabenzamidazole, 6-azabenzamidazole, anthranil, benzisoxazole, and benzoxazole, benzofuran, benzothiophene, benzothiazole, benzoisothiophene, quinoline, isoquinoline, and quinozoline; optionally substituted with at least one —OH, —CH 3 , —NH 2 , —NO 2 , —F, —CI, or —Br substituents;

contacting the microorganism with the one or more test compounds; and

determining a level of growth or replication of the microorganism;

wherein a difference in the level of growth or replication of the microorganism as compared to the level in a control identifies that the one or more test compounds modulate the growth or replication of the microorganism.

10. A method of preparing and identifying a test compounds that modulate the growth or replication of a microorganism, the method comprising the steps of:

(a) incubating a first compound and a second compound in the presence of at least one oxygenase to produce an extract;

wherein the first compound is indole optionally substituted with at least one —OH, —CH 3 , —NH 2 , —NO 2 , —F, —CI, or —Br substituents, and the second compound is selected from the group consisting of indole, indene, isoindoline, 2-azaindole, 3-azaindole, 4-azaindole, 5-azaindole, 6-azaindole, 7-azaindole, benzimidazole, benzamidazoline, imidazopyridine, 4-azabenzamidazole, 5-azabenzamidazole, 6-azabenzamidazole, anthranil, benzisoxazole, and benzoxazole, benzofuran, benzothiophene, benzothiazole, benzoisothiophene, quinoline, isoquinoline, and quinozoline; optionally substituted with at least one —OH, —CH 3 , —NH 2 , —NO 2 , —F, —CI, or —Br substituents;

wherein the at least one oxygenase comprises a toluene monooxygenase;

(b) generating one or more test compounds within the extract, wherein the first compound is oxidized by the at least one oxygenase to generate at least one first oxidized product, and the second compound is oxidized by the at least one oxygenase to generate at least one second oxidized product; further wherein the at least one first oxidized product and the at least one second oxidized product react to generate one or more test compounds;

(c) contacting the microorganism with the extract;

(d) determining a level of growth or replication of the microorganism;

wherein a difference in the level of growth or replication of the microorganism as compared to the level in a control identifies that the extract modulates the growth or replication of the microorganism;

(e) isolating the one or more test compounds from the extract;

(f) contacting the microorganism with the one or more test compounds; and

(g) determining a level of growth or replication of the microorganism;

wherein a difference in the level of growth or replication of the microorganism as compared to the level in a control identifies that the test compound that modulates the growth or replication of the microorganism.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded May 28, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
To: APTIM INTELLECTUAL PROPERTY HOLDINGS, LLC (FKA SHAW INTELLECTUAL PROPERTY HOLDINGS, LLC); APTIM GOVERNMENT SOLUTIONS, LLC (FKA CB&I GOVERNMENT SOLUTIONS, LLC)
Reel/Frame 067535/0309 →
SECURITY INTEREST Recorded May 24, 2024
From: APTIM GOVERNMENT SOLUTIONS, LLC; APTIM INTELLECTUAL PROPERTY HOLDINGS, LLC
To: JPMORGAN CHASE BANK, N.A., AS JUNIOR LIEN COLLATERAL AGENT
Reel/Frame 067524/0085 →
SECURITY INTEREST Recorded May 23, 2024
From: APTIM GOVERNMENT SOLUTIONS, LLC; APTIM INTELLECTUAL PROPERTY HOLDINGS, LLC
To: JPMORGAN CHASE BANK, N.A., AS SENIOR SECURED COLLATERAL AGENT
Reel/Frame 067514/0322 →
CHANGE OF NAME Recorded Mar 2, 2018
From: SHAW INTELLECTUAL PROPERTY HOLDINGS, LLC
To: APTIM INTELLECTUAL PROPERTY HOLDINGS, LLC
Reel/Frame 045513/0376 →
SECURITY INTEREST Recorded Jul 6, 2017
From: SHAW INTELLECTUAL PROPERTY HOLDINGS, LLC; CB&I GOVERNMENT SOLUTIONS, LLC; LFG SPECIALTIES, L.L.C.; CB&I ENVIRONMENTAL & INFRASTRUCTURE, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT
Reel/Frame 042915/0657 →
SECURITY INTEREST Recorded Jun 30, 2017
From: SHAW INTELLECTUAL PROPERTY HOLDINGS, LLC; CB&I GOVERNMENT SOLUTIONS, LLC; LFG SPECIALTIES, L.L.C.; CB&I ENVIRONMENTAL & INFRASTRUCTURE, INC.
To: UBS AG, STAMFORD BRANCH, AS ABL COLLATERAL AGENT
Reel/Frame 042875/0116 →
Continuity (3)
Division 12898806 · Oct 6, 2010
Provisional Application 61249396 · Oct 7, 2009
Related Publication 20110212435A1 · Sep 1, 2011